Canada markets close in 5 hours 14 minutes

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
14.14+1.19 (+9.19%)
As of 10:45AM EDT. Market open.
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts18182019
Avg. Estimate-1.65-1.64-6.39-4.84
Low Estimate-2.16-2-7.98-7.09
High Estimate-1.26-1.02-3.962.56
Year Ago EPS-2.46-2.68-9.05-6.39
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts17171919
Avg. Estimate5.66M7.1M34.24M137.45M
Low Estimate2.12M2.45M14.14M35.57M
High Estimate15.08M15.58M80.22M528.73M
Year Ago Sales2.41M2.47M86.45M34.24M
Sales Growth (year/est)134.90%187.40%-60.40%301.40%
Earnings History2023-03-302023-06-292023-09-292023-12-30
EPS Est.-2.5-2.55-2.73-1.28
EPS Actual-2.46-2.68-3.37-0.55
Difference0.04-0.13-0.640.73
Surprise %1.60%-5.10%-23.40%57.00%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-1.65-1.64-6.39-4.84
7 Days Ago-1.61-1.6-6.22-4.72
30 Days Ago-1.6-1.58-6.22-4.76
60 Days Ago-1.6-1.58-6.3-4.9
90 Days Ago-1.46-1.74-6.14-5.44
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days2222
Up Last 30 Days3455
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1132
Growth EstimatesSAGEIndustrySector(s)S&P 500
Current Qtr.32.90%N/AN/AN/A
Next Qtr.38.80%N/AN/AN/A
Current Year29.40%N/AN/AN/A
Next Year24.30%N/AN/AN/A
Next 5 Years (per annum)16.80%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A